Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

September 26, 2024 expert reaction to modelling study looking at whether protection against measles from the MMR vaccine decreases over time . A modelling study published in the L ...

The vast majority of cases of measles in England are in unvaccinated children and young people and outbreaks are always driven by low vaccine coverage, but the proportion of measles cases in adults ...

Data published by the World Health Organisation looks at adolescent social media use and gaming. Prof Ben Carter, Professor of Medical Statistics, Institute of Psychiatry, Psychology & Neuroscience at ...

Parkinson’s is the fastest growing neurological condition in the world, affecting around 153,000 people in the UK. It affects the dopamine-producing neurons in the brain and leads to many symptoms, ...

A follow up of a phase 2 trial published in eClinicalMedicine looks at the effect of psilocybin versus escitalopram for depression. Dr James Rucker, Consultant Psychiatrist & Senior Clinical Lecturer ...

A study published in Cell traces market wildlife to investigate COVID-19 origins. Prof James Wood, Infectious Disease Epidemiologist at the University of Cambridge and Co-Director of Cambridge ...

This study looked at the burden of stroke on society, which is the incidence, death rate and the number of years lost due to disability and death (the Daily Adjusted Life Years, or DALYs). The data ...